Evidence map›Paper›PMID 39403025›Full record

ReviewHistopathology2025

Molecular techniques in haematopathology: what and how?

Gaurav Chatterjee, Rong He, Nikhil Patkar, David Viswanatha, Anton W Langerak

Abstract readReview
In one paragraph

Review in Histopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gaurav ChatterjeeHematopathology Department, ACTREC, Tata Memorial Centre, Mumbai, India.ORCID https://orcid.org/0000-0002-6505-7898
Rong HeDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0001-6116-8163
Nikhil PatkarHematopathology Department, ACTREC, Tata Memorial Centre, Mumbai, India.ORCID https://orcid.org/0000-0001-9234-2857
David ViswanathaDivision of Hematopathology, Mayo Clinic, Rochester, MN, USA.
Anton W LangerakLaboratory Medical Immunology, Department of Immunology, Erasmus MC, Rotterdam, the Netherlands.ORCID https://orcid.org/0000-0002-2078-3220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we review the 'what and how' of molecular techniques used in the context of haematopathological diagnostics of both lymphoid and myeloid neoplasms. Keeping in mind that the required resources for molecular testing are not universally available, we will not only discuss novel and emerging techniques that allow more high-throughput and sophisticated analyses of lymphoid and myeloid neoplasms, but also the more classical, low-cost alternatives and even some workarounds for molecular testing approaches. In this review we also address other key aspects around molecular techniques for haematopatholgy diagnostics, including preanalytics, data interpretation, and data management, bioinformatics, and interlaboratory precision and performance evaluation.

Indexed as

Hematologic NeoplasmsHumansMolecular Diagnostic TechniquesPathology, Molecular

Identifiers

PMID39403025
PMCPMC11648354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.